MSU
APGN

Mizuho Securities USA’s Apexigen, Inc. Common Stock APGN Stock Holding History

Mizuho Securities USA’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-466,704
Closed -$4.71M – 282
2022
Q2 		$4.71M Buy
466,704
+375,459
+411% +$3.8M 0.72% 44
2022
Q1 		$921K Buy
+91,245
New +$915K 0.13% 137
2021
Q4 		– Sell
-12,674
Closed -$126K – 241
2021
Q3 		$126K Buy
+12,674
New +$125K 0.01% 239

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mizuho Securities USA's APGN Position: Q3 2022 in Review

Mizuho Securities USA sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 466,704 shares — an estimated $4.71M sold.

Mizuho Securities USA first reported a position in APGN in Q3 2021 and held it in 3 quarters. The position peaked at $4.71M in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Mizuho Securities USA reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Mizuho Securities USA sold 466,704 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $4.71M.
  • Mizuho Securities USA first reported a position in Apexigen, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Mizuho Securities USA's Apexigen, Inc. Common Stock position peaked at $4.71M in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Mizuho Securities USA's 13F filing for Q3 2022, filed 24 Oct 2022.